E
Tenaya Therapeutics, Inc. TNYA
$0.4912 $0.03066.64% NASDAQ
Recommendation
Prev Close
$0.4912
Volume
3,291,349
Avg Vol (90D)
3,808,835
Market Cap
$79.35M
Dividend & Yield
--
52-Week Range
$0.3941 - $4.96
P/E (TTM)
--
EPS (TTM)
-$1.32
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Top 3 Insider Stock Buys in March—Are They Still Good in April?
3/25/2025 - MarketBeat
Tenaya Therapeutics (TNYA) Unveils Key Data at Upcoming Heart Rhythm Meeting TNYA Stock News
4/24/2025 - GuruFocus
Tenaya announces interim data from ongoing RIDGE study
4/24/2025 - TipRanks Financial Blog
Tenaya Therapeutics Presents Interim Data from RIDGE Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025
4/24/2025 - Globe Newswire
Insiders Are Loving These 5 Tech and Biotech Stocks
4/2/2025 - 24/7 Wall St.
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Short Interest Down 22.1% in March
4/1/2025 - MarketBeat
Tenaya Therapeutics (NASDAQ:TNYA) Receives "Buy" Rating from HC Wainwright
4/1/2025 - MarketBeat
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Sees Significant Decline in Short Interest
3/31/2025 - Ticker Report
Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK -1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting
3/31/2025 - Globe Newswire
Is Tenaya Therapeutics, Inc. (TNYA) the Cheapest Stock Insiders Are Buying In March?
3/28/2025 - Insider Monkey
Is Tenaya Therapeutics, Inc. (TNYA) the Cheapest Stock Insiders Are Buying In March?
3/28/2025 - Yahoo! Finance: News
15 Cheapest Stocks Insiders Are Buying In March
3/25/2025 - Insider Monkey
Tenaya Therapeutics, Inc. (TNYA): Among Stocks Receiving the Most Insider Love in March
3/25/2025 - Insider Monkey
Top 3 Insider Stock Buys in March Are They Still Good in April?
3/25/2025 - MarketBeat
Breakeven On The Horizon For Tenaya Therapeutics, Inc. (NASDAQ:TNYA)
3/24/2025 - Simply Wall St
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function ...
3/24/2025 - GuruFocus
Tenaya Therapeutics publishes preclinical data on TN-201 in cardiac function
3/24/2025 - The Fly
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models
3/24/2025 - Globe Newswire
Tenaya Therapeutics announces $300M mixed shelf offering; shares down
3/21/2025 - SeekingAlpha.com: All News
Tenaya Therapeutics files $300M mixed securities shelf
3/21/2025 - The Fly
Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College ...
3/19/2025 - GuruFocus
Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology's Annual Scientific Session
3/19/2025 - Globe Newswire
Tenaya Therapeutics (NASDAQ:TNYA) Given New $6.00 Price Target at Canaccord Genuity Group
3/14/2025 - MarketBeat
Tenaya Therapeutics price target lowered by $12 at Canaccord, here's why
3/13/2025 - The Fly
Tenaya Therapeutics (NASDAQ:TNYA) Price Target Lowered to $9.00 at Chardan Capital
3/13/2025 - Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$107.48M
EBIT (TTM)
-$115.95M
Net Income (TTM)
-$111.13M
Balance Sheet
Total Assets (Q)
$119.94M
Total Debt (Q)
$13.61M
Total Liabilities (Q)
$27.09M
Book Value Per Share (Q)
$1.07
Cash Flow
Cash from Operations (TTM)
-$90.50M
Cash from Investing (TTM)
$1.13M
Cash from Financing (TTM)
$47.75M
Net Change in Cash (TTM)
-$41.62M
Filings
Filing Date
Monday, March 10, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
2.71
7-Day Total Return
6.34%
30-Day Total Return
-29.72%
60-Day Total Return
-53.66%
90-Day Total Return
-82.14%
Year to Date Total Return
-65.41%
1-Year Total Return
-88.60%
2-Year Total Return
-89.58%
3-Year Total Return
-94.82%
5-Year Total Return
--
52-week Low
Mar 04, 2025 - $0.3941
52-week High
May 03, 2024 - $4.96
Valuation
Market Cap
$79.35M - Micro Cap
Enterprise Value
$31.51M
Price/Sales (TTM)
--
Price/Book (Q)
0.46
Dividends and Shares
Shares Outstanding
86.41M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.tenayatherapeutics.com
Phone Number
650 825 6990
Address
171 Oyster Point Boulevard
South San Francisco, CA 94080
Country
United States
Year Founded
2016
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. The company’s lead product candidate... more
NASDAQ 04/25/2025 4:00PM Eastern Quotes delayed